Duell, Johannes, Maddocks, Kami J, Gonzalez-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Ales, Gaidano, Gianluca, Abrisqueta, Pau et al (show 11 more authors)
(2021)
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
.
Item Type: | Conference or Workshop Item (Unspecified) |
---|---|
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
Depositing User: | Symplectic Admin |
Date Deposited: | 12 Jul 2021 09:44 |
Last Modified: | 19 May 2022 02:17 |
DOI: | 10.3324/haematol.2020.275958 |
Open Access URL: | https://doi.org/10.3324/haematol.2020.275958 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3129744 |
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)